✦ LIBER ✦

Subtype G and Multiple Forms of A/G Intersubtype Recombinant Human Immunodeficiency Virus Type 1 in Nigeria

✍ Scribed by Francine E. McCutchan; Jean K. Carr; Mary Bajani; Eric Sanders-Buell; Tekena O. Harry; Thomas C. Stoeckli; Kenneth E. Robbins; Wadzani Gashau; Abdulsalam Nasidi; Wouter Janssens; Marcia L. Kalish

Book ID: 112272198
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 345 KB
Volume: 254
Category: Article
ISSN: 0042-6822
DOI: 10.1006/viro.1998.9505

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Full Genome Sequences of Human Immunodef

Full Genome Sequences of Human Immunodeficiency Virus Type 1 Subtypes G and A/G Intersubtype Recombinants

✍ Jean K. Carr; Mika O. Salminen; Jan Albert; Eric Sanders-Buell; Deanna Gotte; De 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 469 KB

Defining the human immunodeficiency viru

Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms

✍ Andile Nofemela; Gama Bandawe; Ruwayhida Thebus; Jinny Marais; Natasha Wood; Oli 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 988 KB

The first B/G intersubtype recombinant f

The first B/G intersubtype recombinant form of human immunodeficiency virus type 1 (HIV-1) identified in Germany was undetected or underquantitated by some commercial viral load assays

✍ Inge von Truchsess; Barbara Harris; Hermann M. Schätzl; John Hackett Jr. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

The high level of genetic diversity of human immunodeficiency virus type 1 (HIV-1) and the continual emergence of recombinant forms have important implications not only for the global evolution of HIV but also for diagnosis, monitoring, and treatment strategies. The present study reports the first i

Detection of distinct human immunodefici

Detection of distinct human immunodeficiency virus Type 1 circulating recombinant forms in Northeast Brazil

✍ Luciane Amorim Santos; Joana Paixao Monteiro-Cunha; Adriano Fernando Araujo; Car 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

## Abstract The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose significant challenges for vaccine development and antiretroviral therapy efficacy. The objective of this study was to characterize the molecular profile of HIV‐1 epidemic in Salvador, Bahi

Effect of human immunodeficiency virus t

Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G

✍ Ana Carolina Palma; Ana Barroso Abecasis; Jurgen Vercauteren; Ana Patricia Carva 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Europe is currently observing a significant rise in non-B subtypes. Consequently, the effect of genetic variability on therapy response or genotypic resistance interpretation algorithms is an emerging concern. The purpose of this study is to investigate the amino acid substitutions selected under dr

Human immunodeficiency virus type 1 (HIV

Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G

✍ Frank A.J. Konings; Sherri T. Burda; Mateusz M. Urbanski; Ping Zhong; Arthur Nad 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB

Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form (CRF) 02\_AG is the predominant subtype in Cameroon, even more prevalent than the parental subtypes A and G. An important question that needs to be addressed is whether recombination in HIV-1 infection can lead to the emergence